NCT05047211View on ClinicalTrials.gov

Intravenous Iron vs. Oral Iron Supplementation for Postpartum Anemia

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 7, 2021

Primary Completion Date

March 15, 2023

Study Completion Date

April 15, 2023

Conditions
Anemia, Iron DeficiencyDelivery Complication
Interventions
DRUG

Ferrous sulfate

one tablet 325 milligrams three times a day

DRUG

Iron dextran

1000 mg intravenous infusion

Trial Locations (1)

77555

Ashley Salazar, Galveston

All Listed Sponsors
lead

The University of Texas Medical Branch, Galveston

OTHER

NCT05047211 - Intravenous Iron vs. Oral Iron Supplementation for Postpartum Anemia | Biotech Hunter | Biotech Hunter